1315 Capital

1315 Capital is a private equity firm specializing in growth-stage healthcare investments. The firm focuses on commercial-stage companies across healthcare services, medical technology, pharmaceuticals, and health & wellness sectors. With over $1 billion in assets under management, 1315 Capital partners with management teams to scale businesses that positively impact patients, physicians, and the broader healthcare system.

The firm's investment strategy targets companies with significant growth potential, aiming to scale them into large and important businesses. 1315 Capital employs an Operating Team model, engaging experienced executives to navigate diligence, drive decisions, and achieve premium exits. This approach leverages a large network for management talent, advisors, deal sourcing, and board roles to support the growth of its portfolio companies.

Since its founding in 2014, 1315 Capital has made 34 platform investments, with portfolio companies experiencing over $500 million in revenue growth. The firm has been recognized on Inc.'s 2025 Founder-Friendly Investors list, highlighting its role as a trusted partner to founders in the healthcare industry. Typical equity investments range from $15 million to $50 million, targeting businesses with the potential to reach $50 million to $200 million in revenue, a level attractive for acquisition or access to public markets.